Search
Pirifibrate
go.drugbank.com/drugs/DB20620ExperimentalPirifibrate has a monoisotopic molecular weight of 335.09 Da. … The usage of the INN stem '-fibrate' in the name indicates that Pirifibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist.
Salafibrate
go.drugbank.com/drugs/DB20767ExperimentalSalafibrate has a monoisotopic molecular weight of 646.14 Da. … The usage of the INN stem '-fibrate' in the name indicates that Salafibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist.
Nicofibrate
go.drugbank.com/drugs/DB19916ExperimentalNicofibrate has a monoisotopic molecular weight of 305.08 Da. … The usage of the INN stem '-fibrate' in the name indicates that Nicofibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist.
Dulofibrate
go.drugbank.com/drugs/DB20032ExperimentalDulofibrate has a monoisotopic molecular weight of 324.03 Da. … The usage of the INN stem '-fibrate' in the name indicates that Dulofibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist.
Elarofiban anhydrous
go.drugbank.com/drugs/DB21212ExperimentalElarofiban anhydrous has a monoisotopic molecular weight of 416.24 Da. … The usage of the INN stem '-fiban' in the name indicates that Elarofiban anhydrous is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).
Lifibrate
go.drugbank.com/drugs/DB21399ExperimentalLifibrate has a monoisotopic molecular weight of 409.08 Da. … The usage of the INN stem '-fibrate' in the name indicates that Lifibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist.
Dazdotuftide
go.drugbank.com/drugs/DB21550InvestigationalDazdotuftide has a monoisotopic molecular weight of 1005.48 Da. … Dazdotuftide is under investigation in clinical trial NCT05042609 (A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma).
Muvalaplin
go.drugbank.com/drugs/DB21568InvestigationalMuvalaplin has a monoisotopic molecular weight of 710.4 Da. … Muvalaplin is under investigation in clinical trial NCT05563246 (A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events).
ChulaCov19 mRNA vaccine
go.drugbank.com/drugs/DB16445ExperimentalThe next phase of this study is for phase I and II clinical trials (NCT04566276) beginning in January 2021. … Pre-clinical studies in mice and monkeys showed evidence that the vaccine facilitates an impressive generation of neutralizing antibodies[L30678].
Alphameprodine
go.drugbank.com/drugs/DB01499ExperimentalIllicitAlphameprodine is a structural analogue of meperidine. … Alphameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances.